Cannabis Stocks Rally to Best Weekly Performance Since Early 2024
Cannabis equities surge on regulatory optimism and sector rotation as investors position for potential federal policy shifts.
Cannabis stocks are experiencing their strongest weekly performance in nearly two years, with the AdvisorShares Pure US Cannabis ETF (MSOS) climbing over 12% this week alone. The sector-wide rally reflects renewed investor confidence following a prolonged period of underperformance that has plagued cannabis equities throughout most of 2024 and early 2025.
The current momentum stems from multiple catalysts converging simultaneously. Fresh speculation around federal rescheduling efforts has reignited institutional interest, while several state-level regulatory developments have created optimism for expanded market access. Multi-state operators like Curaleaf (CURLF), Green Thumb Industries (GTBIF), and Trulieve (TCNNF) are leading the charge, with each posting double-digit gains as trading volumes spike to levels not seen since the initial rescheduling announcements in 2024.
Investor sentiment has shifted dramatically from the pessimism that dominated cannabis markets through the end of 2025. The sector's historically high correlation with regulatory news cycles means that even modest policy developments can trigger significant price movements. Current trading patterns suggest institutional money is rotating back into cannabis names after months of retail-driven selling pressure that pushed many MSO valuations to multi-year lows.
The rally comes at a critical juncture for cannabis operators, many of whom have struggled with compressed margins and limited access to traditional banking services. Companies with strong balance sheets and established market positions stand to benefit most from any sustained uptick in investor interest. However, the sector's notorious volatility means this week's gains could prove ephemeral without concrete regulatory progress.
While cannabis stocks remain down significantly from their 2021 peaks, this week's performance demonstrates the sector's potential for explosive moves when fundamental catalysts align with technical momentum. The key question facing investors is whether current gains represent the beginning of a sustained recovery or another false start in the cannabis sector's volatile journey toward mainstream acceptance.